Overview
US occupational health provider's Q1 revenue rose 13.7% yr/yr, beating analyst expectations
Adjusted EPS for Q1 increased yr/yr; no analyst estimate provided for comparison
Company declared cash dividend and raised full-year 2026 guidance
Outlook
Concentra now sees 2026 revenue between $2.275 bln and $2.375 bln
Company expects 2026 adjusted EBITDA of $460 mln to $480 mln
Concentra forecasts 2026 free cash flow between $215 mln and $235 mln
Result Drivers
VISIT VOLUME GROWTH - Co said meaningful growth in patient visit volumes, particularly in workers' compensation and employer services, drove Q1 results
HIGHER REVENUE PER VISIT - Revenue per visit increased 3.1% yr/yr, supporting overall revenue growth
NETWORK EXPANSION - Co opened one de novo occupational health center and acquired three centers, increasing total locations
Company press release: ID:nBw8T1C40a
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$569.56 mln
$553.50 mln (7 Analysts)
Q1 EPS
$0.39
Q1 Net Income
$52.29 mln
Q1 Adjusted EBITDA
$120.70 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Concentra Group Holdings Parent Inc is $28.50, about 24.9% above its May 6 closing price of $22.82
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)